Medrad Inc. introduced at the American Healthcare Radiology Administrators (AHRA) Annual Meeting the XDS, a new extravasation detector technology for the Stellant CT Injection System that, for the first time, directly senses extravasation pooling under the skin during a CT procedure.
The Medrad XDS extravasation detector is a patented product designed to prevent moderate to severe contrast extravasations that may seriously injure patients. Using radio frequency (RF) wave technology and a physical property called permittivity, XDS can detect the start of an extravasation under the patient’s skin and signal the Stellant to stop injecting until a clinician can examine the patient.


Related Content

News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Contrast Media

May 16, 2023 — Bracco Imaging, an innovative world leader delivering end-to-end products and solutions through a ...

Time May 16, 2023
arrow
Feature | Contrast Media | By Christine Book

In the past year, the radiology community has been a first-hand, hands-on witness to myriad unexpected challenges and ...

Time May 03, 2023
arrow
Sponsored Content | Videos | Contrast Media

Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...

Time February 27, 2023
arrow
News | Contrast Media

February 16, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...

Time February 16, 2023
arrow
Feature | Contrast Media Injectors | By Christine Book

The vital, and growing role of contrast media, and the medical devices employed to inject the agent into the body ...

Time January 19, 2023
arrow
News | Computed Tomography (CT)

December 12, 2022 — GE Healthcare announced an agreement with ulrich medical for a GE Healthcare branded contrast media ...

Time December 12, 2022
arrow
News | Contrast Media

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
News | Contrast Media

August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...

Time August 03, 2022
arrow
Subscribe Now